MAM
FOLD

McCarthy Asset Management’s Amicus Therapeutics FOLD Stock Holding History

McCarthy Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4,415
Closed -$43K – 355
2021
Q2 		$43K Hold
4,415
– – 0.03% 101
2021
Q1 		$44K Buy
+4,415
New +$68.3K 0.03% 97

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

McCarthy Asset Management's FOLD Position: Q3 2021 in Review

McCarthy Asset Management sold out of Amicus Therapeutics (FOLD) in Q3 2021, closing a stake of 4,415 shares — an estimated $43K sold.

McCarthy Asset Management first reported a position in FOLD in Q1 2021 and held it in 2 quarters. The position peaked at $44K in Q1 2021. 237 funds tracked by Wall St. Rank hold FOLD as of Q3 2021.

  • McCarthy Asset Management reported no remaining Amicus Therapeutics position as of Q3 2021 after selling out during the quarter.
  • McCarthy Asset Management sold 4,415 Amicus Therapeutics shares in Q3 2021, an estimated $43K.
  • McCarthy Asset Management first reported a position in Amicus Therapeutics in Q1 2021 and held it in 2 quarters.
  • McCarthy Asset Management's Amicus Therapeutics position peaked at $44K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2021.

Based on McCarthy Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.